Skip to main content
. 2021 Jan 15;78(7):3181–3203. doi: 10.1007/s00018-020-03733-2

Fig. 3.

Fig. 3

KEGG-based map of altered metabolites and associated pathways derived from the major metabolomics studies in MS patients and EAE